Leishmaniasis

Common Name(s)

Leishmaniasis

Leishmaniasis is a parasitic disease spread by the bite of infected sand flies. There are several different forms of leishmaniasis. The most common are cutaneous and visceral. The cutaneous type causes skin sores. The visceral type affects internal organs such as the spleen, liver and bone marrow. People with this form usually have fever, weight loss, and an enlarged spleen and liver. Visceral disease can be deadly without proper treatment. Leishmaniasis is found in parts of the Middle East, Central America, South American, Asia, Africa, and southern Europe. Most of these countries are in the tropics and subtropics. It is possible but very unlikely to get this disease in the United States.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Leishmaniasis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Leishmaniasis" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Leishmaniasis" returned 2353 free, full-text research articles on human participants. First 3 results:

Clinical, laboratory, and therapeutic characteristics of American tegumentary leishmaniasis in the 15 th State Health Division, Northwest Paraná State, Southern Brazil.
 

Author(s): Priscila Wolf Nassif, Marcela Castilho-Peres, Ana Paula Zanatta Rosa, Aline Laureano da Silva, Sandra Mara Alessi Aristides, Maria Valdrinez Campana Lonardoni, Jorge Juarez Vieira Teixeira, Thaís Gomes Verzignassi Silveira

Journal: Rev. Soc. Bras. Med. Trop.. ;49(5):593-601.

 

American tegumentary leishmaniasis (ATL) is an endemic disease in many regions of Brazil; however, only few reports on the actual epidemiological conditions are available. Here, we aimed to assess the clinical, epidemiological, and laboratory characteristics of ATL patients and their ...

Last Updated: 4 Nov 2016

Go To URL
The challenges on developing vaccine against visceral leishmaniasis.
 

Author(s): Selma Maria Bezerra Jerônimo, Richard D Pearson

Journal: Rev. Soc. Bras. Med. Trop.. ;49(4):395-7.

 

Last Updated: 7 Sep 2016

Go To URL
Leishmaniasis in high-burden countries: an epidemiological update based on data reported in 2014.
 

Author(s):

Journal: Wkly. Epidemiol. Rec.. 2016 Jun;91(22):287-96.

 

Last Updated: 3 Jun 2016

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Leishmaniasis" returned 229 free, full-text review articles on human participants. First 3 results:

Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis.
 

Author(s): Mariana Costa Duarte, Daniela Pagliara Lage, Vívian Tamietti Martins, Miguel Angel Chávez-Fumagalli, Bruno Mendes Roatt, Daniel Menezes-Souza, Luiz Ricardo Goulart, Manuel Soto, Carlos Alberto Pereira Tavares, Eduardo Antonio Ferraz Coelho

Journal: Rev. Soc. Bras. Med. Trop.. ;49(4):398-407.

 

Visceral leishmaniasis (VL) is one of the most important tropical diseases worldwide. Although chemotherapy has been widely used to treat this disease, problems related to the development of parasite resistance and side effects associated with the compounds used have been noted. Hence, ...

Last Updated: 7 Sep 2016

Go To URL
Laboratory diagnosis of human visceral leishmaniasis.
 

Author(s): Hercules Sakkas, Constantina Gartzonika, Stamatina Levidiotou

Journal: J Vector Borne Dis. 2016 Mar;53(1):8-16.

 

Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a vector-borne systemic disease, with a worldwide distribution causing high morbidity and mortality in the developing world. VL patients may be asymptomatic or they may present symptoms and findings of a systemic ...

Last Updated: 23 Mar 2016

Go To URL
Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective.
 

Author(s): Om Prakash Singh, Bhawana Singh, Jaya Chakravarty, Shyam Sundar

Journal:

 

Visceral leishmaniasis (VL) is a serious parasitic disease causing considerable mortality and major disability in the Indian subcontinent. It is most neglected tropical disease, particularly in terms of new drug development for the lack of financial returns. An elimination campaign ...

Last Updated: 8 Mar 2016

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Predicting Visceral Leishmaniasis in HIV Infected Patients
 

Status: Not yet recruiting

Condition Summary: Leishmaniasis, Visceral

 

Last Updated: 6 Jan 2017

Go to URL

Last Updated: 22 May 2016

Go to URL
Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis
 

Status: Not yet recruiting

Condition Summary: Mucocutaneous Leishmaniasis

 

Last Updated: 24 Apr 2015

Go to URL